Loss of heterozygosity of the distal region of chromosome 1p where tumor suppressor gene(s) might harbor is frequently observed in many human cancers including neuroblastoma (NBL) with MYCN ampli®cation and poor prognosis. We have identi®ed for the ®rst time a homozygously deleted region at the marker D1S244 within the smallest region of overlap at 1p36.2-p36.3 in two NBL cell lines, NB-1 and NB-C201 (MASS-NB-SCH1), although our genotyping has suggested the possibility that both lines are derived from the same origin. The 800-kb PAC contig covering the entire region of homozygous deletion was made and partially sequenced (about 60%). The estimated length of the deleted region was 500 kb. We have, thus far, identi®ed six genes within the region which include three known genes (DFF45, PGD, and CORT) as well as three other genes which have been reported during processing our present project for the last 3 years (HDNB1/UFD2, KIAA0591F/KIF1B-b, and PEX14). They include the genes related to apoptosis, glucose metabolism, ubiquitinproteasome pathway, a neuronal microtubule-associated motor molecule and biogenesis of peroxisome. At least three genes (HDNB1/UFD2, KIAA0591F/KIF1B-b, and PEX14) were dierentially expressed at high levels in favorable and at low levels in unfavorable subsets of primary neuroblastoma. Since the 1p distal region is reported to be imprinted, those dierentially expressed genes could be the new members of the candidate NBL suppressor, although RT-PCR-SSCP analysis has demonstrated infrequent mutation of the genes so far identi®ed. Full-sequencing and gene prediction for the region of homozygous deletion would elucidate more detailed structure of this region and might lead to discovery of additional candidate genes. Oncogene (2000) 19, 4302 ± 4307.
Keywords: neuroblastoma; homozygous deletion; 1p36; tumor suppressor gene Neuroblastoma (NBL) is one of the most common pediatric tumors and originates from the sympathoadrenal lineage derived from the neural crest (Bolande, 1974) . It shows various clinical behaviors ranging from spontaneous regression to malignant progression. Genetic aberrations frequently found in NBL are loss of the distal part of the short arm of chromosome 1 (1p), ampli®cation of the MYCN oncogene and 17q gain, all of which are associated with an unfavorable prognosis (Brodeur et al., 1984; Caron, 1995) . 1p loss also occurs frequently in other tumors such as colorectal cancer, hepatocellular cancer, breast cancer, pheochromocytoma, and melanoma (Schwab et al., 1996) . Fluorescence in situ hybridization (FISH) and loss of heterozygosity (LOH) analysis have been applied to de®ne the deleted region of 1p in NBL in many laboratories, suggesting that at least three putative NBL suppressor loci might be present at the distal region of 1p, especially at 1p36.1-pter (Martinsson et al., 1995; White et al., 1995; Amler et al., 1995; Ichimiya et al., 1999) , 1p36.1-p35 (Cheng et al., 1995) and 1p34-p32 (Takeda et al., 1994; Schleiermacher et al., 1994) . With respect to 1p36, about 7 cM region between markers D1S214 and D1S244 is a smallest region of overlap (SRO) of deletion by taking into account all LOH studies (Martinsson et al., 1995; White et al., 1995) . To date, several candidate tumor suppressor genes mapped to the distal 1p have been reported. They include CDC2L1 (Lahti et al., 1994) , p73 (Kaghad et al., 1997) , TNFR2 (White et al., 1993) , RIZ (He et al., 1998) , DAN (Enomoto et al., 1994) , FGR (Dracopoli et al., 1988) , EXTL (Wise et al., 1997), and hRAD54 (Carling et al., 1999) . However, their mutations so far examined are infrequent in NBLs.
Detection of a homozygous deletion (HD) in tumor cells is the most ecient way to isolate tumor-related genes. We screened 29 NBL cell lines for HD by PCR using 15 polymorphic markers (D1S80, p73, D1S214, D1S548, D1S160, D1S508, D1S450, D1S244, TNFR2, D1S228, D1S507, D1S483, D1S2843, D1S458 and FGR) and found two cell lines (NB-1 and MASS-NB-SCH1) with deletion at a D1S244 marker. MASS-NB-SCH1 (abbreviated to NB-C201 in this paper) was a recently established cell line from the primary tumor found by mass screening at the age of 6 months (Hiraiwa et al., 1997) . Figure 1a shows the results of LOH in NB-C201 for the markers of D1S548, D1S244, D1S507 and FGR, among which only D1S244 was homozygously deleted. Further analysis using markers around the D1S244 locus revealed that additional ®ve markers (D1S2021, D1S1768, D1S2736, SGC30343, and PGD) were also lost in both cell lines (Figure 1b) . We then PCR-screened DNA from 180 primary NBLs at D1S244. However, it failed to ®nd clear HD probably because of contamination of the stromal cell components.
To de®ne the homozygously deleted region, we assembled a sequence-ready clone contig that spanned the region of deletion. We developed a contig using P1 arti®cial chromosomes (PACs) containing SGC30343, D1S2021, D1S1768, PGD, D1S244, and D1S2736, the markers that de®ned the HD. The ends of the isolated PAC clones were sequenced to develop new sequence tagged sites (STSs) for further screening of clones and for securing the overlaps between the clones (Figure 2 ). The insert sizes of the PAC clones constituting the minimum tiling path of the contig were determined by using restriction digestion with NotI and/or SalI followed by pulsed-®eld gel electrophoresis (PFGE). According to the PFGE data, the size of the contig was estimated to be approximately 800 kb. Using the PAC end sequences, both breakpoints in the two cell lines were mapped between dJ1028O13-SP6 and dJ371E1-SP6, and D1S2736 and dJ142A6-T7, as shown in Figure 2 . Accordingly, the HD region represented approximately 500 kb or less.
The HD in NBL has been uncommon. Only the neuro®bromatosis-1 (NF1) gene on chromosome 17q11.2 Martinsson et al., 1997) and the p16 gene on 9q21 (Diccianni et al., 1996) have been reported to be homozygously lost in NBL. Our precise analysis revealed that the breakpoints of the HD region in two cell lines were identical in cDNA sequences, within the HDNB1/UFD2 and PEX14 genes (data not shown). Both genes were fused to produce a chimeric transcript, suggesting that the deletion occurred in the very limited genomic region in both cell lines and that the deletion hotspot might exist in this region. However, it raised the possibilities that these two cell lines were originated from the same patient or cross-contaminated. The former possibility was excluded by referring the original reports (Imashuku et al., 1973; Hiraiwa et al., 1997) . To clarify the latter point, we re-obtained the original cell stock and con®rmed that it lost the D1S244 region. In the previous paper, Hiraiwa et al. (1997) performed genotyping and con®rmed establishment of a new cell line. The cell morphology and responsiveness to retinoic acid in MASS-NB-SCH1/NB-C201 line were dierent from those in NB-1 (unpublished data). Nevertheless, our genotyping in several loci displayed very similar patterns in both cell lines. These suggested a possibility that the origin of NB-1 and MASS-NB-SCH1 cells was the same, though that should be further pursued.
In the next step, gene identi®cation was performed by cDNA library screening and by rough genome sequencing using six minimum PAC clones (dJ587C9, dJ371E1, dJ694C14, dJ756A17, dJ266I16, and dJ345P21). We identi®ed at least six genes in this region. The EST marker SGC30343 revealed to be a part of a 4.6 kb novel gene, which we named HDNB1 (a homozygously deleted gene in neuroblastoma 1, accession no. AB028839) after cloning by screening the fetal brain cDNA library. Recently, it was shown to correspond to a human homolog of yeast ubiquitin fusion degradation 2 (UFD2, locus designation: LOH at the region of chromosome 1p35-p36 was performed using 29 NBL cell lines and 206 primary NBL samples (data not shown). During the analysis, D1S244 revealed to be homozygously deleted in case 201 and NB-1 cell line, although these two cell lines have a possibility to be derived from the same origin (see text). The NB-C201 cell line was a gift from Dr M Hamazaki and Dr H Hiraiwa (Department of Pathology, Shizuoka Children's Hospital). It was established from the NBL tissue obtained from a right paravertebral region of the mediastinum of a 7-month-old NBL patient who was found by the mass screening program (Hiraiwa et al., 1997) . On the other hand, NB-1 cell line was derived from a lesion metastatic to cervical lymph node obtained from a 2-year-old patient with NBL (Imashuku et al., 1973) . (b) Detection of the homozygous deletion at six loci. As an internal control, NGFb primers on 1p13 were used in the same reaction. Template DNAs for PCR reaction are SY5Y (lanes 1, 4, 7, 10, 13, 16), NB-1 (lanes 2, 5, 8, 11, 14, 17) , and NB-C201 (3, 6, 9, 12, 15, 18) . The ampli®ed product of the NGFb is shown by an arrow, and the product from each marker is shown by an arrowhead Oncogene Homozygous deletion at 1p36.2 in a human neuroblastoma cell M Ohira et al UBE4B) which catalyzes ubiquitin chain assembly in conjugation with E1, E2 and E3 in proteolysis pathways (Johnson et al., 1995; Pukatzki et al., 1998; Koegl et al., 1999) . The E4 activity is linked to cell survival under stress conditions in yeast, indicating that eukaryotes utilize E4-dependent proteolysis pathways for multiple cellular functions. HDNB1 cDNA we isolated was likely to be a short form (an alternatively spliced transcript) of the human UFD2 (6.0 kb, accession no. NM004788).
By direct cDNA library screening with PAC DNAs, we found that a kinesin-related gene KIAA0591 (Nagase et al., 1998) resided in PAC clone dJ756A17 and that three genes, phosphogluconate dehydrogenase (PGD) (Tsui et al., 1996) , DNA fragmentation factor 45 (DFF45, locus designation: DFFA)/inhibitor of caspase-activated DNase (ICAD) (Liu et al., 1997) , and neuron-speci®c preprocortistatin (CORT/CST) (Fukusumi et al., 1997; de Lecea et al., 1997) resided in dJ266I16 (Figure 2 ). DFF45/ICAD sequence was also found in the PAC end sequence dJ373D24-SP6. The KIAA0591 had previously been isolated in a 5'-truncated form by KAZUSA DNA Research Institute (Nagase et al., 1998) , and we extended the cDNA to a full-length form (7.7 kb) by screening a human substantia nigra cDNA library (named KIAA0591F as full-length KIAA0591, accession no. AB017133) (Nagai et al., 2000) . We recently found that this gene might be a human homolog of a mouse kinesin-superfamily member Kif1b-b (submitted only in a database, accession no. AB023656), whose product had an Nterminal motor domain homologous to Kif1b (Nangaku et al., 1994) and a novel C-terminal cargo-binding domain homologous to Kif1a (Takemura et al., 1996) . There may be additional alternatively spliced transcripts in the HD region from the analysis of the genome sequence (unpublished data), so the genome structure of these kinesin-related genes should be further elucidated. DFF45/ICAD regulates the DNA fragmentation activity of DFF40/CAD in the apoptotic process. The intact structure/conformation of DFF45 is essential for functioning as a speci®c chaperone and assisting in the proper synthesis of active DFF40 (Enari et al., 1998) . Although the signi®cance of DNA fragmentation in apoptosis has not yet been well clari®ed, distortion of the DNA fragmentation system may negatively in¯uence on the apoptotic process. PGD is ubiquitously expressed, and its product is a catalytic enzyme that works in the hexose monophosphate shunt which supplies NADPH and pentoses for the nucleic acid metabolism. CORT/CST is a presumptive neuropeptide that shares 11 of 14 amino acids with somatostatin. CORT/CST mRNA is expressed in a subset of GABAergic interneurons in the Figure 2 Genome structure of the homozygously deleted region. To cover the HD region, 40 PACs were isolated and aligned in an 800-kb contig. The PAC library consisting of 1440 multiwell microtiter plates was provided by Dr Pieter de Jong (Rosewell Park Institute, Bualo, NY, USA) (Ioannou et al., 1994) . The end fragments of the PAC clones were sequenced directly from the clone DNA with P6S and T7 vector primers using an ALF Express TM DNA sequencer (Amersham Pharmacia Biotech). On the PAC end, the direction of the insert is noted: N; T7 end, S; SP6 end. New STSs for genomic walking were designed from nonrepetitive end sequences. De®nition of the deletion ends was performed by PCR with these primers using genomic DNAs of NB-1, NB-C201, and human placenta. The insert sizes of the PAC clones were determined by restriction digestion followed by pulsed-®eld gel electrophoresis (PFGE). NotI-digested PAC DNA was separated in 1% agarose gel using a CHEF DRII pulsed-®eld gel electrophoresis apparatus (BIORAD). The region deleted in NB-1 and NB-C201 cell lines (approximately 500-kb long) was shown on the top and also shaded in the map. The distal and proximal breakpoints were mapped between dj1028O13-SP6 and dJ371E1-SP6, and between D1S2736 and dJ142A6-T7, respectively. For gene identi®cation, cDNA libraries were screened with PAC DNAs or an EST fragment containing SCG30343. In addition, rough genome sequencing of the PAC clones was also performed as described previously (Hattori et al., 1997) . cDNA libraries we used were derived from human fetal brain purchased from Clontech or a human NBL cDNA library we constructed from primary NBLs with favorable prognosis. cDNA clones were extended by RACE PCR using fetal brain Marathon-ready TM cDNA as a template (Clontech). The six genes mapped to the HD region were illustrated with transcription directions. The transcriptional direction of each gene was determined using primers that can work in genomic DNAs. Genomic primer sequences were as follows: PEX14 (5')-genome; (f)GATATGGCCTTCCAGCAGTC; (r)ATATG-AGGTGAGGGGGCTGG, PEX14 (3')-genome; (f)GAGGAGGAGAAGAGGGAGGA; (r)AGAGAGGGAGGCAGGGTATG, PGD(5')-genome; (f)AGCCCAGGGTTGGAGAAC; (r)TTACAGCCATGGGCCACT, PGD(3')-genome; (f)CACGAAGAACG-CATGAGG; (r)TCCCCAGCCATGTCTGTAA, CORT(5')-genome; (f)TGCCATGAAGGGTGAAGG; (r)AAGGAGGCATTTC-CAGCA, and CORT(3')-genome; (f)GGGTGCTTTTTGTGCTGAA; (r)CCATTCGATCACACACCATT cortex and hippocampus (Fukusumi et al., 1997; de Lecea et al., 1997) . This gene could also be one of the good candidates of NBL-related gene. However, Martinsson et al. have recently reported that there is no signi®cant alteration in this gene in NBLs (Fifth International Human Chromosome 1 Workshop '99 at Sanger Centre, UK).
Rough genome sequencing followed by homology searching also detected the above ®ve genes, and an additional gene, PEX14 was identifed in a PAC clone dJ345P21 (Figure 2) . The PEX14 gene product is a central component of the peroxisomal protein import machinery . The Cterminus of the protein exposes to the cytoplasm and binds the receptor for the peroxisomal targeting signal 1 (PTS1), and the N-terminus might protrude into the peroxisomal lumen in yeast. Thus, the genes within the HD region could functionally be tumor suppressors.
For precise mapping of these six genes on the PAC clones, 5' and 3'-end primers that should work in genomic DNA were designed. Each location and transcriptional direction of the genes were determined by PCR using PAC DNAs as indicated in Figure 2 .
The Sanger Centre mapped several hundreds of ESTs and genes on chromosome 1 by radiation hybrid mapping (Genemap '99). Of these, ESTs corresponding to HDNB1/UFD2, PGD, DFF45/ICAD and PEX14 were positioned within the interval de®ned by D1S450 and D1S2667 that agreed with our localization. However, KIAA0591F/KIF1B-b and CORT/CST genes were not localized, suggesting that both genes were new entries to the map. In addition, three genes KIAA0911, PIK3CD, and SCYA5 were positioned in this region (between D1S450 and D1S2667, Genemap '99), but we localized these genes outside the 500-kb deleted region by PCR using NB-1 and NB-C201 cell lines (data not shown). Thus, HDNB1/UFD2, KIAA0591F/KIF1B-b, PGD, CORT/CST, DFF45/ICAD, and PEX14 were located in the 500 kb HD region.
We carried out RT-PCR using cDNAs prepared from eight NBL cell lines including NB-1 and NB-C201. Primers were synthesized in at least two positions in each gene (close to the 5'-and 3'-ends). Expression of three central genes (KIAA0591F/KIF1B-b, PGD, and DFF45/ICAD) were absolutely lost in both NB-1 and NB-C201, while obvious expression was seen in other control cell lines (Figure 3a) . Expression of CORT/CST was also lost in NB-1 and NB-C201 and was generally low in other NBL cell lines (data not shown). The transcripts of HDNB1/UFD2 and PEX14 were found to be truncated in 3'-and 5'-portion of the genes, respectively, in the two cell lines (Figure 3a) . The breakpoints in the cDNA sequences were mapped between n.t. 719 and 720 in the former (just downstream of a putative translation start site) and between n.t. 173 and 174 in the latter. These results suggested that HDNB1/UFD2 and PEX14 would not have their normal cellular cellular forms in NB-1 and NB-C201.
According to the Knudson's two-hit theory on the tumor suppressor genes (Knudson, 1971) , mutation search for all the genes in this region is necessary. To survey mutations in those genes, RT-PCR-SSCP analyses were performed (see Table 1 ). We surveyed 23 primary NBLs and 17 NBL cell lines for HDNB1/ UFD2, KIAA0591F/KIF1B-b, PGD and PEX14, and 26 primary NBLs and 21 NBL cell lines for DFF45/ICAD. So far, no base substitution was found in KIAA0591F cDNA (the motor domain was not screened). Three base changes were found in DFF45/ICAD, but without amino acid substitutions as described elsewhere (Furuta et al., submitted) . PEX14 had several mutations, four silent mutations and a missense mutation (codon 320) from arginine to lysine in two NBL cell lines (OAN, LA-N-6, see Table 1 ). There was an amino acid substitution in HDNB1/UFD2 from asparagine to serine (codon 593) in a NBL cell line (LHN cell). Thus, mutations in the genes within the HD region were infrequent.
The epigenetic regulation of the tumor suppressor genes is important (Jones and Laird, 1999) . In addition, 1p36 is the region which is imprinted (Caron et al., 1993) . We examined mRNA expression of the six Figure 3 The expression status of the genes in the HD region in NBL. (a) Expression of the ®ve genes in 7 NBL cell lines and HeLa cell. RT-PCR was performed using cDNA primers and control GAPDH primers. Primers were designed to work only in the cDNAs but not in genomic DNAs. Primer sequences were as follows: HDNB1(5'); (f)AGTAGTCTGTGGGGCGACTG; (r)GTTGGC-TGAGAGGTCTGTCC, HDNB1(3'); (f)AACGCTGAGACCT-GAAAGGA; (r)GCAGCAAAATGTCCAAGGTT, PEX14(5'); (f)GTCCTCGGAGCAGGCAGAG; (r)ATATGAGGTGAGGG-GGCTGG, PEX14(3'); (f)ATCCCAGTCAAGTCACCGTC; (r)ATCCTCCTCATCCTCCTCGT, KIAA0591F; (f)CAGCAA-GATGAGATGGAGGA; (r)GCAGTGACTTCTCTAGACTA-GG, PGD; (f)TCTTGGCCAATGAGGCAAAG; (r)ATGAAAT-CATCCACAGCTTG, and DFF45/ICAD; (f)CTGCACCAACAA-TATCCC; (r)GTAGAGACAGGGTTTCAC. 3' region of the HDNB1/UFD2 and 5' region of the PEX14 are not transcribed in NB-C201 and NB-1. (b) Semi-quantitative RT-PCR in favorable and unfavorable NBLs. cDNAs synthesized from eight favorable tumors and from eight unfavorable tumors with MYCN ampli®ca-tion were used. Those cDNAs were at ®rst ampli®ed with Cy5-labeled GAPDH primers in 25 cycles and the amounts of the PCR products were measured by ALF Express TM sequencer and normalized. The band intensities were measured by Intelligent Quanti®er (Bio Image). The ratios of the average in favorable and unfavorable tumors were 3.2 : 1 (HDNB1/UFD2), 3.6 : 1 (KIAA0591F/KIF1Bb), 3.2 : 1 (DFF45/ICAD), 1.6 : 1 (PGD) and 2.2 : 1 (PEX14)
Oncogene Homozygous deletion at 1p36.2 in a human neuroblastoma cell M Ohira et al genes in 16 primary NBLs with favorable or unfavorable prognosis by semi-quantitative RT-PCR. Expression of all genes except CORT/CST were detectable in all samples (Table 1) . HDNB1/UFD2, DFF45/ICAD and KIAA0591F/KIF1B-b were expressed at signi®-cantly higher levels in favourable stage I tumors than in unfavorable tumors with MYCN ampli®cation (Figure 3b ). Although the reduction of gene dosage caused by allelic loss might at least partly aect the expression levels, there might also be an epigenetic modi®cation. Of interest, KIAA0591F/KIF1B-b was expressed 3.6 times higher in favorable NBL than in unfavorable one. CORT/CST, whose expression in NBL is very low, could also be one of the candidate genes, although it was dicult to compare levels of expression between normal and malignant tissues because of a diculty in obtaining normal tissue.
Thus, we identi®ed for the ®rst time a 500-kb homozygous deletion that was located within one of the SROs at the distal region of 1p in NBL cell line(s). Construction of a sequence-ready PAC contig enabled us to de®ne the 500-kb HD region and to clone and map the genes. cDNA cloning and rough genome sequencing of about 60% led to the identi®cation of six genes in this region. Four genes were dierentially expressed at high levels in favorable NBLs as compared to unfavorable ones. Since the 1p distal region was reported to be imprinted, those genes dierentially expressed could be the candidate NBL suppressor(s) regulated by epigenetic modi®cation. Nevertheless, as RT-PCR-SSCP analysis showed infrequent mutation for the genes so far identi®ed, we need to search for additional candidate genes by fullsequencing for the entire region of the HD. An extensive search for additional unknown genes within the region is in progress by gene prediction.
